Esta página se tradujo automáticamente y no se garantiza la precisión de la traducción. por favor refiérase a versión inglesa para un texto fuente.

Standard Medical Care or Urgent Chest X-ray in Diagnosing Lung Cancer in Smokers With Chest Symptoms Who Are Older Than 60 Years

23 de agosto de 2013 actualizado por: Wales Cancer Trials Unit

A Pilot Clinical Trial Looking at the Effect on Lung Cancer Diagnosis of Giving a CXR to Smokers Aged Over 60 With Chest Symptoms

RATIONALE: Diagnostic procedures, such as an urgent chest x-ray, may help in planning cancer treatment. It is not yet known whether standard medical care is more effective than an urgent x-ray in diagnosing lung cancer in smokers with chest symptoms who are older than 60 years.

PURPOSE: This randomized clinical trial is studying standard medical care to see how well it works compared with an urgent chest x-ray in diagnosing lung cancer in smokers with chest symptoms who are older than 60 years.

Descripción general del estudio

Descripción detallada

OBJECTIVES:

Primary

  • To determine the prevalence of extra-NICE symptoms in patients consulting in UK general practice.
  • To determine the proportion of patients who agree to participate in the trial.
  • To determine the proportion of patients who are diagnosed with lung cancer and the best sources of routine data for capturing lung cancers.

Secondary

  • To determine the best way to train general practitioners to identify and recruit eligible patients into the trial.
  • To determine the most effective method of presenting the trial (and randomization) to patients.
  • To determine the barriers to recruitment and how to overcome those barriers.
  • To determine the best tools to use to measure anxiety/depression that may be caused by unnecessary chest-x-rays or no chest x-rays.
  • To determine the best measures of resource use to facilitate health economic analysis of the cost-effectiveness of 'extra-NICE'.
  • To determine the stage at diagnosis, performance status, and the proportion of patients receiving radical treatments in those diagnosed with lung cancer.

OUTLINE: This is a multicenter study. Patients are randomized to 1 of 2 treatment arms.

  • Arm A: Patients are managed as per the National Institute for Health and Clinical Excellence (NICE) guidelines.
  • Arm B: Patients are referred for an urgent chest x-ray according to extra-NICE guidelines.

General practitioners from South East Wales are surveyed to assess their level of interest in the proposed full trial. For the feasibility study, 20 South East Wales general practices and 6 South Yorkshire general practices are selected. General practitioners are trained to recruit all patients who fulfill the extra-NICE criteria as well as those who do not.

Patients complete questionnaires (HADS, EQ-5D, and ICECAP[O]) at baseline and at 2 months to measure quality of life and health economic analysis of the cost-effectiveness of extra-NICE guidelines.

Peer Reviewed and Funded or Endorsed by Cancer Research UK.

Tipo de estudio

Intervencionista

Inscripción (Anticipado)

386

Fase

  • No aplica

Criterios de participación

Los investigadores buscan personas que se ajusten a una determinada descripción, denominada criterio de elegibilidad. Algunos ejemplos de estos criterios son el estado de salud general de una persona o tratamientos previos.

Criterio de elegibilidad

Edades elegibles para estudiar

60 años y mayores (Adulto, Adulto Mayor)

Acepta Voluntarios Saludables

No

Géneros elegibles para el estudio

Todos

Descripción

DISEASE CHARACTERISTICS:

  • Patients over 60 seeing a participating General Practitioner
  • Currently smokes 10 or more pack years, meeting at least one of the following criteria:

    • New or altered cough of any duration reported to primary care
    • Increased breathlessness or wheezing (with or without purulent sputum)
  • Do not qualify for an urgent referral for a chest x-ray under the National Institute for Health and Clinical Excellence (NICE) guidelines (i.e., hemoptysis or unexplained or persistent [lasting > 3 weeks] signs or symptoms), including having any of the following:

    • Cough
    • Chest/shoulder pain
    • Dyspnea
    • Weight loss
    • Chest signs
    • Hoarseness
    • Finger clubbing
    • Features suggestive of metastasis from a lung cancer (e.g., in the brain, bone, liver, or skin)
    • Cervical/supraclavicular lymphadenopathy

PATIENT CHARACTERISTICS:

  • Not specified

PRIOR CONCURRENT THERAPY:

  • No chest x-ray within in past 3 months
  • No need for a chest x-ray within the next 3 weeks for reasons other than those listed under Disease Characteristics

Plan de estudios

Esta sección proporciona detalles del plan de estudio, incluido cómo está diseñado el estudio y qué mide el estudio.

¿Cómo está diseñado el estudio?

Detalles de diseño

  • Propósito principal: Diagnóstico
  • Asignación: Aleatorizado
  • Enmascaramiento: Ninguno (etiqueta abierta)

¿Qué mide el estudio?

Medidas de resultado primarias

Medida de resultado
Prevalence of extra-NICE symptoms in patients consulting in UK general practice
Proportion of patients who agree to participate in the trial
Proportion of patients who are diagnosed with lung cancer and the best sources of routine data for capturing lung cancers

Medidas de resultado secundarias

Medida de resultado
Best way to train general practitioners to identify and recruit eligible patients into the trial
Most effective method of presenting the trial (and randomization) to patients
Barriers to recruitment and how to overcome those barriers
Best tools to use to measure anxiety/depression that may be caused by unnecessary chest-x-rays or no chest x-rays
Best measures of resource use to facilitate health economic analysis of the cost-effectiveness of 'extra-NICE'
Stage at diagnosis, performance status, and the proportion of patients receiving radical treatments in those diagnosed with lung cancer
False-positive and false-negative rates for chest x-rays

Colaboradores e Investigadores

Aquí es donde encontrará personas y organizaciones involucradas en este estudio.

Investigadores

  • Investigador principal: Richard Neal, MD, North Wales Clinical School

Publicaciones y enlaces útiles

La persona responsable de ingresar información sobre el estudio proporciona voluntariamente estas publicaciones. Estos pueden ser sobre cualquier cosa relacionada con el estudio.

Fechas de registro del estudio

Estas fechas rastrean el progreso del registro del estudio y los envíos de resultados resumidos a ClinicalTrials.gov. Los registros del estudio y los resultados informados son revisados ​​por la Biblioteca Nacional de Medicina (NLM) para asegurarse de que cumplan con los estándares de control de calidad específicos antes de publicarlos en el sitio web público.

Fechas importantes del estudio

Inicio del estudio

1 de junio de 2011

Finalización primaria (Anticipado)

1 de junio de 2013

Fechas de registro del estudio

Enviado por primera vez

27 de abril de 2011

Primero enviado que cumplió con los criterios de control de calidad

27 de abril de 2011

Publicado por primera vez (Estimar)

28 de abril de 2011

Actualizaciones de registros de estudio

Última actualización publicada (Estimar)

26 de agosto de 2013

Última actualización enviada que cumplió con los criterios de control de calidad

23 de agosto de 2013

Última verificación

1 de abril de 2011

Más información

Esta información se obtuvo directamente del sitio web clinicaltrials.gov sin cambios. Si tiene alguna solicitud para cambiar, eliminar o actualizar los detalles de su estudio, comuníquese con register@clinicaltrials.gov. Tan pronto como se implemente un cambio en clinicaltrials.gov, también se actualizará automáticamente en nuestro sitio web. .

Ensayos clínicos sobre Trastorno por consumo de tabaco

Ensayos clínicos sobre administración del cuestionario

Suscribir